Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulinG antibodies, and enhances protective immunity to Blastomyces dermatitidisinfection
M. Wuthrich et al., Interleukin 12 as an adjuvant to WI-1 adhesin immunization augments delayed-type hypersensitivity, shifts the subclass distribution of immunoglobulinG antibodies, and enhances protective immunity to Blastomyces dermatitidisinfection, INFEC IMMUN, 68(12), 2000, pp. 7172-7174
Cell-mediated immunity is pivotal in host resistance to Blastomyces dermati
tidis infection. Immunization of mice with the WI-1 adhesin enhances resist
ance against experimental pulmonary infection but elicits features of a mix
ed T-helper-cell immune response. Immune mice acquire delayed-type hypersen
sitivity (DTH) but also high titers of WI-1-specific immunoglobulin G1 (IgG
1) and IgG2b, a result indicative of T-helper-2 cellular immunity. We repor
t that interleukin-12, used as an adjuvant for WI-1 immunization, augments
DTH, shifts the balance of the T-helper phenotype toward Th1, and enhances
resistance to B. dermatitidis infection.